A61K31/4985 - page 10 - CPC Classification Index

#2701

20130156795

2013-06-20

METHODS FOR INHIBITION OF CELL PROLIFERATION, SYNERGISTIC TRANSCRIPTION MODULES AND USES THEREOF

#2702

20130156707

2013-06-20

PLANT EXTRACTS MADE OF SIDERITIS AND USE THEREOF TO BOOST COGNITIVE PERFORMANCE

#2703

20130150578

2013-06-13

Hypoglycemic compounds

#2704

20130150346

2013-06-13

Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome

#2705

20130142873

2013-06-06

Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-]pyrazin-2(1)-one, a solid form thereof and methods of their use

#2706

20130137698

2013-05-30

Solid oral film dosage forms and methods for making same

#2707

20130137696

2013-05-30

Substituted 3,4-dihydro-2H-pyrrolo[1,2-a]pyrazin-1-ones as modulators of protein kinase activity

#2708

20130131073

2013-05-23

FUSED-IMIDAZOYL COMPOUNDS USEFUL AS ANTIMICROBIAL AGENTS

#2709

20130131054

2013-05-23

Tetracyclic compounds

#2710

20130130974

2013-05-23

Methods of synthesis of β-aminobutyryl substituted compounds

#2711

20130123237

2013-05-16

Cyclic azabenzimidazole derivatives useful as anti-diabetic agents

#2712

20130116262

2013-05-09

Bicyclic piperazine compounds

#2713

20130116257

2013-05-09

METHOD FOR TREATING A PULMONARY HYPERTENSION CONDITION

#2714

20130116245

2013-05-09

Alkylated piperazine compounds

#2715

20130116235

2013-05-09

Heteroaryl pyridone and aza-pyridone compounds

#2716

20130115193

2013-05-09

Hepatitis C Virus Inhibitors

#2717

20130109671

2013-05-02

Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases

#2718

20130102613

2013-04-25

Treatment of cancer with TOR kinase inhibitors

#2719

20130101630

2013-04-25

HIGHLY PURE VARENICLINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF SUBSTANTIALLY FREE OF METHYLVARENICLINE IMPURITY

#2720

20130101622

2013-04-25

IMIDAZOQUINOXALINE COMPOUNDS AS IMMUNOMODULATORS

#2721

20130096120

2013-04-18

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#2722

20130096110

2013-04-18

Pyrazolopyridine, pyrarolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction

#2723

20130095180

2013-04-18

TIME-DELAYED SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION COMPRISING DAPOXETINE FOR ORAL ADMINISTRATION

#2724

20130085144

2013-04-04

Substituted pyrazolo[3,4-b]pyridines as medicaments

#2725

20130078649

2013-03-28

Methods for identifying a GLP-1 secretagogue

#2726

20130072494

2013-03-21

Inhibitors of Jun N-terminal kinase

#2727

20130072493

2013-03-21

N-[4-(1H-PYRAZOLO[3,4-b]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS

#2728

20130072477

2013-03-21

TREATMENT OF PARKINSON'S DISEASE AND ENHANCEMENT OF DOPAMINE SIGNAL USING PDE 10 INHIBITOR

#2729

20130072459

2013-03-21

PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE AND THE METHOD FOR PREVENTION OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE USING THE SAME

#2730

20130072427

2013-03-21

GPR 119 MODULATORS

#2731

20130065904

2013-03-14

Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders

#2732

20130065895

2013-03-14

Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction

#2733

20130059852

2013-03-07

Compounds for treating disease, for administering, and for pharmaceutical compositions

#2734

20130059807

2013-03-07

Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions

#2735

20130059002

2013-03-07

Pharmaceutical compositions comprising a combination of metformin and sitagliptin

#2736

20130053368

2013-02-28

Methods for treatment of Parkinson's disease

#2737

20130045974

2013-02-21

Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

#2738

20130040893

2013-02-14

TREATMENT OF PROLIFERATIVE DISORDERS

#2739

20130039996

2013-02-14

Potentiation of cancer chemotherapy by 7-(2, 5-dihydro-4-imidazo [1, 2-a] pyridine-3-yl-2,5-dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro -2-(1-piperidinyl-carbonyl)-pyrrolo [3,2,1-jk] [1,4] benzodiazepine

#2740

20130035340

2013-02-07

sGC STIMULATORS OR sGC ACTIVATORS ALONE AND IN COMBINATION WITH PDE5 INHBITORS FOR THE TREATMENT OF CYSTIC FIBROSIS

#2741

20130035334

2013-02-07

Inhibitors of bruton's tyrosine kinase

#2742

20130030174

2013-01-31

Composition for reducing skin wrinkles including PDE5 inhibitor

#2743

20130029997

2013-01-31

Deuterated pyrazinoisoquinoline compounds

#2744

20130029996

2013-01-31

SPECIAL COMPOSITION FOR THE USE THEREOF AS A DRUG

#2745

20130029994

2013-01-31

N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors

#2746

20130023530

2013-01-24

NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders

#2747

20130023524

2013-01-24

Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it

#2748

20130023522

2013-01-24

Benzamides

#2749

20130018060

2013-01-17

INHIBITORS OF BRUTON'S TYROSINE KINASE

#2750

20130017273

2013-01-17

Substituted pyrrolo[2,3-B]pyrazines as ATR kinase inhibitors

#2751

20130012488

2013-01-10

Benzoxepin PI3K inhibitor compounds and methods of use

#2752

20130005734

2013-01-03

THERAPEUTIC COMPOSITIONS

#2753

20130005733

2013-01-03

COMBINATION ANTI-CANCER THERAPY

#2754

20130005655

2013-01-03

Methods of treating insomnia using a combination therapy of low-dose doxepin and zolpidem

#2755

20120329806

2012-12-27

Fluoroergoline analogs

#2756

20120329804

2012-12-27

Pyridopyrazindione derivative and its use as an antiulcer drug

#2757

20120329800

2012-12-27

Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors

#2758

20120329796

2012-12-27

COMPOUNDS USEFUL FOR TREATING PREMATURE AGING AND IN PARTICULAR PROGERIA

#2759

20120329130

2012-12-27

INHIBITORS OF BRUTON'S TYROSINE KINASE

#2760

20120322753

2012-12-20

Production method of solid preparation and the solid preparations produced by the method

#2761

20120315331

2012-12-13

Pharmaceutical composition for the treatment of acute disorders

#2762

20120315330

2012-12-13

Pharmaceutical composition for the treatment of acute disorders

#2763

20120309736

2012-12-06

Cyclic benzimidazole derivatives useful as anti-diabetic agents

#2764

20120309714

2012-12-06

Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors

#2765

20120302942

2012-11-29

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, Alzheimer'S disease, sleep disorders, Parkinson'S disease, AIDS, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

#2766

20120302575

2012-11-29

Methods for preventing oxidative stress injury of a tissue by a Folate-TEMPOL conjugate

#2767

20120302573

2012-11-29

METHODS OF INHIBITING PRO MATRIX METALLOPROTEINASE ACTIVATION

#2768

20120301427

2012-11-29

Chemokine receptor binding heterocyclic compounds with enhanced efficacy

#2769

20120296089

2012-11-22

INHIBITORS OF BRUTON'S TYROSINE KINASE

#2770

20120295904

2012-11-22

Hematopoietic growth factor mimetic small molecule compounds and their uses

#2771

20120295898

2012-11-22

Antiviral Therapy

#2772

20120295864

2012-11-22

Method for treating acute myeloid leukemia

#2773

20120283265

2012-11-08

Compounds useful for treating AIDS

#2774

20120282255

2012-11-08

METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALCOHOLISM AND ALCOHOL DEPENDENCE

#2775

20120277255

2012-11-01

Inhibitors of bruton's tyrosine kinase

#2776

20120277238

2012-11-01

PHARMACEUTICAL COMPOSITION CONTAINING FUSED HETERO-RING DERIVATIVE

#2777

20120277230

2012-11-01

COMPOUNDS USEFUL FOR TREATING CANCER

#2778

20120277225

2012-11-01

Inhibitors of Bruton'S tyrosine kinase

#2779

20120277150

2012-11-01

3-hydroxyisothiazole 1-oxide derivatives

#2780

20120276152

2012-11-01

SYSTEMS AND METHODS OF USING ZINC-CHELATOR TO TREAT MYOCARDIAL INFARCTION

#2781

20120270881

2012-10-25

Conformationally constrained, fully synthetic macrocyclic compounds

#2782

20120270880

2012-10-25

Pyrrolo [2,3—D] pyrazin—7—ylpyrimidine compounds

#2783

20120270844

2012-10-25

METHODS FOR TREATING ALZHEIMER'S DISEASE

#2784

20120270836

2012-10-25

Therapeutic approaches for treating alzheimer'S disease

#2785

20120269898

2012-10-25

COMPOSITIONS AND METHODS OF TREATING PULMONARY HYPERTENSION

#2786

20120264739

2012-10-18

Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor

#2787

20120264722

2012-10-18

Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction

#2788

20120259151

2012-10-11

Pyridopyrazine derivatives and their use

#2789

20120258080

2012-10-11

Pyridopyrazines as highly selective ras-Raf-Mek-Erk signal transduction pathway inhibitors

#2790

20120255502

2012-10-11

PACKAGE AND METHOD OF MARKETING

#2791

20120253036

2012-10-04

AGENT FOR TREATING FIBROMYALGIA

#2792

20120252816

2012-10-04

Use of phosphodiesterase inhibitors for treating multidrug resistance

#2793

20120252760

2012-10-04

NOVEL PYRIDOPYRAZINES AND THEIR USE AS MODULATORS OF KINASES

#2794

20120252758

2012-10-04

Bicyclic pyridinones

#2795

20120245179

2012-09-27

Method Of Therapeutic Administration of DHE To Enable Rapid Relief Of Migraine While Minimizing Side Effect Profile

#2796

20120245178

2012-09-27

Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor

#2797

20120238568

2012-09-20

Pyrido[2,3-b]pyrazin-8-substituted compounds and their use

#2798

20120238564

2012-09-20

Imidazo pyrazines

#2799

20120237590

2012-09-20

CURCUMIN COMBINATION WITH ANTI-TYPE 2 DIABETIC DRUGS FOR PREVENTION AND TREATMENT OF DISEASE SEQUELAE, DRUG-RELATED ADVERSE REACTIONS, AND IMPROVED GLYCEMIC CONTROL

#2800

20120232052

2012-09-13

Aryl carboxamide derivatives as TTX-S blockers

#2801

20120232003

2012-09-13

COMPOSITIONS AND METHODS FOR DIABETES TREATMENT

#2802

20120231543

2012-09-13

Opioid antagonists

#2803

20120225844

2012-09-06

Bicyclic triazole and pyrazole lactams as allosteric modulators of mGluR5 receptors

#2804

20120214997

2012-08-23

Method of preparing sitagliptin and intermediates used therein

#2805

20120208819

2012-08-16

Heterocyclic compounds useful as PDK1 inhibitors

#2806

20120208808

2012-08-16

Pyrazolopyrimidine derivatives

#2807

20120208795

2012-08-16

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ADDICTION AND OTHER NEUROPSYCHIATRIC DISORDERS

#2808

20120208172

2012-08-16

Methods of Increasing Liver Proliferation

#2809

20120203147

2012-08-09

VASODILATOR-ENHANCED CARDIOPULMONARY RESUSCITATION

#2810

20120202821

2012-08-09

Conformationally constrained, fully synthetic macrocyclic compounds

#2811

20120202264

2012-08-09

INHIBITORS OF IL2-INDUCIBLE T-CELL KINASE

#2812

20120196881

2012-08-02

Treatment of pulmonary hypertension with carbonic anhydrase inhibitors

#2813

20120195955

2012-08-02

Sublingual films

#2814

20120184567

2012-07-19

INHIBITORS OF BRUTON'S TYROSINE KINASE

#2815

20120184486

2012-07-19

Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives

#2816

20120184013

2012-07-19

Inhibitors of BMX non-receptor tyrosine kinase

#2817

20120178753

2012-07-12

Inhibitors of Bruton's tyrosine kinase

#2818

20120178748

2012-07-12

[1,2,4] triazol [1,5-a] pyrazines useful as inhibitors of phosphodiesterases

#2819

20120165328

2012-06-28

INHIBITORS OF B LYMPHOCYTE KINASE

#2820

20120157461

2012-06-21

Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancer

#2821

20120157399

2012-06-21

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF OBESITY AND DIABETES

#2822

20120149709

2012-06-14

Deuterated pyrazinoisoquinoline compounds

#2823

20120148560

2012-06-14

NEUROPROTECTION FROM BRAIN ANOXIA AND REPERFUSION INJURY DURING STROKE AND COMPOSITIONS OF PKG PATHWAY ACTIVATORS AND METHOD OF USE THEREOF

#2824

20120142582

2012-06-07

Combination of dopamine agonists plus first phase secretagogues for the treatment of metabolic disorders

#2825

20120141454

2012-06-07

Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic Diseases

#2826

20120135987

2012-05-31

Phenylimidazole derivatives as PDE10A enzyme inhibitors

#2827

20120134887

2012-05-31

Sexual dysfunction

#2828

20120129867

2012-05-24

Inhibitors of protein kinases

#2829

20120129856

2012-05-24

Compounds, compositions and methods useful for cholesterol mobilisation

#2830

20120129836

2012-05-24

Tricyclic imidazole compounds as PDE10 inhibitors

#2831

20120128665

2012-05-24

PRESELECTION OF SUBJECTS FOR THERAPEUTIC TREATMENT BASED ON HYPOXIC STATUS

#2832

20120123164

2012-05-17

Process for preparation of trans 4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1Napthalenamine

#2833

20120122878

2012-05-17

Combination products

#2834

20120122874

2012-05-17

COMBINATION OF A SEDATIVE AND A NEUROTRANSMITTER MODULATOR, AND METHODS FOR TREATING DEPRESSION

#2835

20120122842

2012-05-17

NAMPT and rock inhibitors

#2836

20120122835

2012-05-17

Substituted derivatives of pyrido[3,2-e][1,4]thiazino[4,3-a]pyrazine and pyrido[3,2-e][1,4]oxazino[4,3-a]pyrazine

#2837

20120115875

2012-05-10

(3S,11aR)-N-[2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide useful as anti-HIV agent

#2838

20120115849

2012-05-10

Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors

#2839

20120115839

2012-05-10

Use of selective GABA A α5 negative allosteric modulators for the treatment of central nervous system conditions

#2840

20120108613

2012-05-03

Compounds and compositions for treating chemical warfare agent-induced injuries

#2841

20120108564

2012-05-03

Substituted thiazoles as HIV integrase inhibitors

#2842

20120108562

2012-05-03

Therapeutic compositions and methods

#2843

20120107312

2012-05-03

Combinations for the treatment of diseases involving cell proliferation

#2844

20120107300

2012-05-03

Cannabinoid Compositions and Methods

#2845

20120107246

2012-05-03

METHOTREXATE-MODIFIED NANOPARTICLES AND RELATED METHODS

#2846

20120101114

2012-04-26

INHIBITORS OF BRUTON'S TYROSINE KINASE

#2847

20120101113

2012-04-26

INHIBITORS OF BRUTON'S TYROSINE KINASE

#2848

20120088766

2012-04-12

Fused 2-aminothiazole compounds

#2849

20120083483

2012-04-05

Inhibitors of hepatitis C virus replication

#2850

20120071483

2012-03-22

Therapeutic approaches for treating alzheimer disease and related disorders through a modulation of cell stress response

#2851

20120064072

2012-03-15

Combination Cancer Therapy Comprising Administration of an EGFR Inhibitor and an IGF-1R Inhibitor

#2852

20120058942

2012-03-08

METHODS FOR CONTROLLING BLOOD-GLUCOSE LEVELS IN INSULIN-REQUIRING SUBJECTS

#2853

20120058160

2012-03-08

Particulate materials

#2854

20120053175

2012-03-01

Substituted pyrrolo[2,3-B]pyridines as MLK inhibitors

#2855

20120053168

2012-03-01

FUSED BENZOAZEPINES AS NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS

#2856

20120046296

2012-02-23

Palatable ductile chewable veterinary composition

#2857

20120046295

2012-02-23

Compounds useful as inhibitors of ATR kinase

#2858

20120046232

2012-02-23

COMPOSITIONS AND METHODS FOR REDUCING RELAPSE OF ADDICTIVE BEHAVIOR

#2859

20120035182

2012-02-09

Methods of treatment of chronic pain using eszopiclone

#2860

20120028972

2012-02-02

BIOMARKER ASSAYS FOR DETECTING OR MEASURING INHIBITION OF TOR KINASE ACTIVITY

#2861

20120027733

2012-02-02

Compositions to effect neuronal growth

#2862

20120027723

2012-02-02

TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION

#2863

20120022071

2012-01-26

Treatment of Comorbid Premature Ejaculation and Erectile Dysfunction

#2864

20120018345

2012-01-26

Treatment of Comorbid Premature Ejaculation and Erectile Dysfunction

#2865

20120015953

2012-01-19

METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALLERGY

#2866

20120010211

2012-01-12

Pharmaceutical composition for treatment of type 2 diabetes

#2867

20120010191

2012-01-12

Pyridone and aza-pyridone compounds and methods of use

#2868

20120010188

2012-01-12

Imidazopyridine Compounds

#2869

20120004235

2012-01-05

METHODS TO TREAT CANCER

#2870

20110319398

2011-12-29

INHIBITION OF YOPS TRANSLOCATION

#2871

20110319394

2011-12-29

Fused heterocyclic compounds

#2872

20110312996

2011-12-22

NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#2873

20110311474

2011-12-22

Tricyclic compounds

#2874

20110306616

2011-12-15

Compounds as cannabinoid receptor ligands

#2875

20110301185

2011-12-08

CANCER TREATMENT METHOD

#2876

20110294767

2011-12-01

BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS

#2877

20110288068

2011-11-24

AZA spiro alkane derivatives as inhibitors of metalloproteases

#2878

20110275558

2011-11-10

Lanthionine synthetase component C-like proteins as molecular targets for preventing and treating diseases and disorders

#2879

20110274648

2011-11-10

Hepatitis C Virus Inhibitors

#2880

20110263606

2011-10-27

SOLID ORAL DOSAGE FORMS COMPRISING TADALAFIL

#2881

20110263498

2011-10-27

Method and composition for enhancement of male erectile function

#2882

20110263493

2011-10-27

Treatment for diabetes in patients inappropriate for metformin therapy

#2883

20110257221

2011-10-20

Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

#2884

20110257190

2011-10-20

CRYSTALLINE FORMS

#2885

20110257185

2011-10-20

Reverse-turn mimetics and method relating thereto

#2886

20110257169

2011-10-20

Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

#2887

20110257167

2011-10-20

Identification of LKB1 mutation as a predictive biomarker for sensitivity to TOR kinase inhibitors

#2888

20110251219

2011-10-13

TREATMENT FOR GLOMERULONEPHRITIS WITH 2-[4-(7-ETHYL-5H-PYRROLO[2,3-B]PYRAZIN-6-YL)PHENYL]PROPAN-2-OL

#2889

20110251179

2011-10-13

3,4-dihydro-2H-pyrrolo[1,2-a]pyrazin-1-one derivatives for the modulation of the activity of protein kinases

#2890

20110245261

2011-10-06

Antiprolactinic veterinary composition for ruminants

#2891

20110245253

2011-10-06

Method for treating a pulmonary hypertension condition

#2892

20110245191

2011-10-06

Parasiticidal compositions comprising multiple active agents, methods and uses thereof

#2893

20110244058

2011-10-06

Compositions and methods for treatment of pulmonary diseases and conditions

#2894

20110237584

2011-09-29

Kynurenine production inhibitor

#2895

20110224178

2011-09-15

Composition and method for treating erectile dysfunction

#2896

20110224128

2011-09-15

METHODS AND COMPOSITIONS FOR TREATMENT OF MUSCULAR DYSTROPHY

#2897

20110218956

2011-09-08

Methods of diagnosing inflammatory bowel disease

#2898

20110218159

2011-09-08

METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2

#2899

20110212892

2011-09-01

AGENT FOR TREATMENT OF DIABETES

#2900

20110207728

2011-08-25

Substituted imidazo[1,2-α]pyrrolo[1,2-]pyrazines for treating respiratory syncytial virus (RSV) infections

#2901

20110206782

2011-08-25

PIPERIDINE MODULATORS OF DOPAMINE RECEPTOR

#2902

20110201614

2011-08-18

Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals

#2903

20110190322

2011-08-04

PURIN DERIVATIVES FOR USE IN THE TREATMENT OF FAB-RELATED DISEASES

#2904

20110190308

2011-08-04

Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes

#2905

20110183940

2011-07-28

Methyl 3-(benzyloxy)-1-(2,2-dihydroxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate and processes for the preparation thereof

#2906

20110171195

2011-07-14

METHODS AND COMPOSITIONS FOR TREATING URINARY TRACT INFECTIONS USING AGENTS THAT MIMIC OR ELEVATE CYCLIC AMP

#2907

20110160219

2011-06-30

Inhibitors of Phosphodiesterase Type 5A for Treating or Preventing Muscle Disease or the Symptoms Thereof in a Patient

#2908

20110160168

2011-06-30

MODULATION OF SOLUBILITY, STABILITY, ABSORPTION, METABOLISM, AND PHARMACOKINETIC PROFILE OF LIPOPHILIC DRUGS BY STEROLS

#2909

20110159114

2011-06-30

COMBINATION COMPRISING AN IRON CHELATOR AND AN ANTI-NEOPLASTIC AGENT AND USE THEREOF

#2910

20110159066

2011-06-30

Methods For Treating Parkinson's Disease

#2911

20110158989

2011-06-30

Substituted 7,8,9,10-tetrahydro-5H-dipyrido[1,2-a:3′,2′-e]pyrazin-6(6aH)-ones

#2912

20110152285

2011-06-23

Pyrrole antifungal agents

#2913

20110150968

2011-06-23

Dissolvable dietary supplement strip and methods for using the same

#2914

20110142956

2011-06-16

Use of a PDE5 inhibitor for treating and preventing hypopigmentary disorders

#2915

20110136875

2011-06-09

Pyrrole inhibitors of S-nitrosoglutathione reductase

#2916

20110136815

2011-06-09

SOLID ORAL FILM DOSAGE FORMS AND METHODS FOR MAKING SAME

#2917

20110135612

2011-06-09

Compositions to effect neuronal growth

#2918

20110135600

2011-06-09

Bicyclic traizole derivatives for treating of tumors

#2919

20110123434

2011-05-26

Combination therapies comprising quinoxaline inhibitors of P13K-alpha for use in the treatment of cancer

#2920

20110112101

2011-05-12

TREATMENT FOR OCULAR-RELATED DISORDERS

#2921

20110105517

2011-05-05

THERAPEUTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS

#2922

20110105486

2011-05-05

Thiazole derivatives

#2923

20110098307

2011-04-28

Crystalline form of eszopiclone, composition, preparation and uses thereof

#2924

20110098306

2011-04-28

Treatment for gastroparesis using sepiapterin

#2925

20110092510

2011-04-21

DPP-IV INHIBITORS FOR USE IN THE TREATMENT OF NAFLD

#2926

20110092456

2011-04-21

Methods of increasing cAMP levels and uses thereof

#2927

20110082150

2011-04-07

Headache pre-emption by dihydroergotamine treatment during headache Precursor events

#2928

20110077200

2011-03-31

COMBINATION THERAPY USING LOW-DOSE DOXEPIN FOR THE IMPROVEMENT OF SLEEP

#2929

20110076291

2011-03-31

Benzoxepin PI3K inhibitor compounds and methods of use

#2930

20110071080

2011-03-24

Methods and compositions for sleep disorders and other disorders

#2931

20110065731

2011-03-17

Uses of DPP-IV inhibitors

#2932

20110065715

2011-03-17

Nogo Receptor Binding Small Molecules to Promote Axonal Growth

#2933

20110064750

2011-03-17

METHOD AND KIT FOR TREATING NICOTINE ADDICTION

#2934

20110059934

2011-03-10

Compounds and compositions useful for the treatment of parasitic diseases

#2935

20110059912

2011-03-10

Combination therapy comprising SGLT inhibitors and DPP4 inhibitors

#2936

20110059905

2011-03-10

Methods of treating disease-induced ataxia and non-ataxic imbalance

#2937

20110052552

2011-03-03

Compositions to effect neuronal growth

#2938

20110052531

2011-03-03

Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy

#2939

20110046141

2011-02-24

USE OF PDE5 INHIBITORS FOR TREATING CIRCADIAN RHYTHM DISORDERS

#2940

20110046072

2011-02-24

SOLID PHARMACEUTICAL FORMULATION WITH DELAYED RELEASE

#2941

20110046071

2011-02-24

GLP-1 Receptor Agonists And Related Active Pharmaceutical Ingredients For Treatment Of Cancer

#2942

20110034472

2011-02-10

Novel Compounds for Treatment of Cancer and Disorders Associated With Angiogenesis Function

#2943

20110034471

2011-02-10

Compositions comprising a phoshodiesterase-5 inhibitor and their use in methods of treatment

#2944

20110028880

2011-02-03

PATCH

#2945

20110015147

2011-01-20

Anti-viral pyrimidine nucleoside analogues

#2946

20110014174

2011-01-20

Lysozyme, A Novel Vasodilator of Sepsis that can be inhibited by a Peroxidase and Hydroxyl Radical Scavengers

#2947

20110009416

2011-01-13

PH INDEPENDENT FORMULATIONS OF 6-(5-CHLORO-2-PYRIDYL)-5-[(4-METHYL-1-PIPERAZINYL)CARBONYLOXY]-7-OXO-6,7-DIHYDRO-5H-PYRROLO[3,4-b]PYRAZINE

#2948

20110008398

2011-01-13

Medicated patch

#2949

20110002976

2011-01-06

Medicated patch

#2950

20100331335

2010-12-30

Inhibitors of Jun N-terminal kinase

#2951

20100317576

2010-12-16

Methods of enhancing diabetes resolution

#2952

20100311704

2010-12-09

Pharmaceutical delivery systems for treatment of substance abuse and other addictions

#2953

20100298320

2010-11-25

Pyrido[2,3-b]pyrazin-8-substituted compounds and their use

#2954

20100291233

2010-11-18

TREATMENT OF NEUROLOGICAL DISORDERS

#2955

20100286155

2010-11-11

ADRENOCORTICAL CARCINOMA TREATMENT

#2956

20100286124

2010-11-11

PROP-2-YN-1-AMINE INHIBITORS OF MONOAMINE OXIDASE TYPE B

#2957

20100285142

2010-11-11

Method of making particles for use in a pharmaceutical composition

#2958

20100284940

2010-11-11

Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile

#2959

20100280038

2010-11-04

Methods of treatment of chronic pain using eszopiclone

#2960

20100261729

2010-10-14

METHODS FOR THE TREATMENT OF ERECTILE DYSFUNCTION USING FISPEMIFENE

#2961

20100260747

2010-10-14

Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease

#2962

20100256361

2010-10-07

Thiazole derivatives

#2963

20100256153

2010-10-07

METHODS FOR PREVENTING OR REDUCING RISK OF MORTALITY

#2964

20100256046

2010-10-07

TREATMENT OF PROLIFERATIVE DISORDERS

#2965

20100249095

2010-09-30

Substituted spiro-amide compounds

#2966

20100239646

2010-09-23

Sublingual methotrexate and methotrexate patches

#2967

20100234467

2010-09-16

METHODS FOR IMPROVING BIOAVAILABILITY OF A RENIN INHIBITOR

#2968

20100234431

2010-09-16

Pyrrolidine compounds

#2969

20100227853

2010-09-09

INHIBITORS OF CYCLIC AMP PHOSPHODIESTERASES

#2970

20100226993

2010-09-09

Composition for regenerative treatment of cartilage disease

#2971

20100221338

2010-09-02

Coated Tablets Of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-Oxo-6,7-Dihydro-5H-Pyrrolo[3,4-b]Pyrazine And Methods For Measuring Effectiveness Of Coating

#2972

20100203146

2010-08-12

INTERMITTENT DOSING STRATEGY FOR TREATING RHEUMATOID ARTHRITIS

#2973

20100202979

2010-08-12

Compositions and methods for treatment of pulmonary diseases and conditions

#2974

20100197658

2010-08-05

PHARMACEUTICAL USE OF FUSED 1,2,4-TRIAZOLES

#2975

20100190763

2010-07-29

Substituted 6a,7,8,9-tetrahydropyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-ones

#2976

20100179159

2010-07-15

Method for the production of a medicament containing tadalafil

#2977

20100179158

2010-07-15

INHIBITORS OF CYCLIC AMP PHOSPHODIESTERASES

#2978

20100166884

2010-07-01

Potentiation of cancer chemotherapy by 7-(2, 5-dihydro-4-imidazo [1, 2-A] pyridine-3-yl-2,5-Dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro-2-(1-piperidinyl-carbonyl)-pyrrolo [3,2,1-jk] [1,4] benzodiazepine

#2979

20100160313

2010-06-24

Substituted pyrimidyl guanidine derivatives having anticancer activity

#2980

20100160292

2010-06-24

Kinase Inhibitors, and Methods of Using and Identifying Kinase Inhibitors

#2981

20100158858

2010-06-24

ADMINISTRATION OF CARBOLINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISEASES

#2982

20100152217

2010-06-17

METHOD FOR TREATING A PULMONARY HYPERTENSION CONDITION

#2983

20100150896

2010-06-17

DIAMINOQUINAZOLINE INHIBITORS OF DIHYDROFOLATE REDUCTASE

#2984

20100144823

2010-06-10

Indole derivatives as selective androgen receptor modulators (SARMS)

#2985

20100144730

2010-06-10

Pyridinonyl PDK1 inhibitors

#2986

20100144613

2010-06-10

Combined use of DPP-IV Inhibitors and Gastrin Compounds

#2987

20100143296

2010-06-10

PODOPHYLLOTOXIN INHIBITORS OF TOPOISOMERASE II

#2988

20100137976

2010-06-03

Systems and Methods for Treating Heart Tissue Via Localized Delivery of Parp Inhibitors

#2989

20100137321

2010-06-03

Imidazo[1,2-a]azines and their use as pharmaceuticals

#2990

20100130504

2010-05-27

Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes

#2991

20100130472

2010-05-27

Bile acid recycling inhibitors for treatment of obesity and diabetes

#2992

20100130426

2010-05-27

Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing agent

#2993

20100113486

2010-05-06

Use of PDE7 inhibitors for the treatment of movement disorders

#2994

20100113484

2010-05-06

TREATING AGENT OF UROPATHY

#2995

20100113455

2010-05-06

Method of reducing intraosseous hypertension

#2996

20100105614

2010-04-29

ULTRA LOW DOSE DOXEPIN AND METHODS OF USING THE SAME TO TREAT SLEEP DISORDERS

#2997

20100096240

2010-04-22

Passenger conveyor handrail drive control strategy

#2998

20100092547

2010-04-15

COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING MUCOSITIS AND WEIGHT LOSS

#2999

20100087370

2010-04-08

MODULATION OF NITRIC OXIDE SIGNALING TO NORMALIZE TUMOR VASCULATURE

#3000

20100081664

2010-04-01

METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE